Analysis Centenial Surgical Suture Limited (CSURGSU)
5/29/2024
Analysis of Centenial Surgical Suture Limited (CSURGSU)
Centenial Surgical Suture Limited (CSURGSU) has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been hovering around 45-50, indicating a neutral sentiment in the market.The Moving Average Convergence Divergence (MACD) indicator has been fluctuating around 0, suggesting a balance between bullish and bearish momentum. The MACD histogram has been negative, indicating a slight bearish pressure.
The Moving Average (MA) indicator has been slightly above the current price, suggesting a potential resistance level. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a stable trend.
Overall, Centenial Surgical Suture Limited seems to be in a consolidation phase with no clear trend direction. Traders and investors may need to wait for a clearer signal before making any significant trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%
2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10 Volume: 52,903,608
- Average 90 Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%
3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book MRQ: 39.181313
- Price to Sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating efficient cost management.
3. The operating income has also shown a positive trend, reflecting good operational performance.
4. The net income has been growing over the years, showing that the company is profitable and able to generate increasing bottom-line results.
5. The earnings per share (EPS) have been relatively stable, with minor fluctuations, suggesting a consistent performance in generating returns for shareholders.
6. The company has been able to maintain a healthy EBITDA margin, indicating strong operational efficiency.
7. Despite fluctuations in certain expenses and income components, the overall financial performance of the company seems robust and improving.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has generally increased over the years, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its growth, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its growth through a combination of liabilities and shareholders' equity, with both showing an increasing trend over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently positive, indicating that the company's core business operations are generating cash.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. Interest paid has also varied over the years, with a noticeable increase in 2023 compared to previous years.
5. The company has been repurchasing common stock and paying dividends, which has had an impact on its financing activities.
6. Investing activities have also fluctuated, with significant amounts spent on the sale and purchase of investments in different years.
7. The end cash position has been relatively stable, with fluctuations depending on the cash flow activities in each fiscal year.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, with a range from $1.27 to $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, with a range from $1.44 to $1.63. This indicates an increase compared to the EPS of $1.46 from the same quarter a year ago.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, with a range from $6.43 to $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range from $6.40 to $7.90. This suggests an increase compared to the EPS of $6.59 from the previous fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It is important to note that these are analyst estimates and actual performance may vary.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the average and median both indicating a price higher than the current price. The low end of the forecast suggests a potential decrease in price, while the high end indicates a significant increase. It's important to consider these different perspectives when making investment decisions.
MACD of CSURGSU
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
